CTOs on the Move


 
Inogen`s mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae`s Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.inogen.com
  • 326 Bollay Drive
    Goleta, CA USA 93117
  • Phone: 855.631.2438

Executives

Name Title Contact Details

Similar Companies

Molecular Biometrics

Molecular Biometrics is a Chester, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kern Surgical Supply

Kern Surgical Supply is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuMeDx

NeuMeDx, Inc. is a Bristol, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

Oncology Services International

Our mission is to form long term trusting relationships with healthcare providers to help them deliver outstanding patient outcomes and experiences. We will never compromise quality in creating value through cost-effective healthcare technology solutions. From the services we provide to the equipment and parts we deliver, we will help our customers meet the challenges of providing high quality care while containing cost.